Mersana Therapeutics Inc [NASDAQ: MRSN] gained 12.69% or 0.04 points to close at $0.38 with a heavy trading volume of 6351559 shares.
It opened the trading session at $0.3458, the shares rose to $0.3895 and dropped to $0.3361, the range by which the price of stock traded the whole day. The daily chart for MRSN points out that the company has recorded -72.06% loss over the past six months.
If we look at the average trading volume of 2.78M shares, MRSN reached to a volume of 6351559 in the most recent trading day, which is why market watchdogs consider the stock to be active.
Here is what top equities market gurus are saying about Mersana Therapeutics Inc [MRSN]:
Based on careful and fact-backed analyses by Wall Street experts, the current consensus on the target price for MRSN shares is $4.50 per share. Analysis on target price and performance of stocks is usually carefully studied by market experts, and the current Wall Street consensus on MRSN stock is a recommendation set at 1.29. This rating represents a strong Buy recommendation, on the scale from 1 to 5, where 5 would mean strong sell, 4 represents Sell, 3 is Hold, and 2 indicates Buy.
William Blair have made an estimate for Mersana Therapeutics Inc shares, keeping their opinion on the stock as Outperform, with their previous recommendation back on February 06, 2025. While these analysts kept the previous recommendation, Citigroup raised their target price to Buy. The new note on the price target was released on November 15, 2024, representing the official price target for Mersana Therapeutics Inc stock. Previously, the target price had yet another raise to $5, while JP Morgan analysts kept a Neutral rating on MRSN stock. On February 29, 2024, analysts increased their price target for MRSN shares from 2 to 7.
Trading performance analysis for MRSN stock
Mersana Therapeutics Inc [MRSN] gain into the green zone at the end of the last week, gaining into a positive trend and gaining by 35.86. With this latest performance, MRSN shares dropped by -2.76% in over the last four-week period, additionally sinking by -72.06% over the last 6 months – not to mention a drop of -73.43% in the past year of trading.
Mersana Therapeutics Inc [MRSN]: A deeper dive into fundamental analysis
Operating Margin for any stock indicates how profitable investing would be, and Mersana Therapeutics Inc [MRSN] shares currently have an operating margin of -225.98% and a Gross Margin at 95.53%. Mersana Therapeutics Inc’s Net Margin is presently recorded at -217.64%.
Return on Equity for this stock declined to -47.62%, with Return on Assets sitting at -47.62%.
Mersana Therapeutics Inc [MRSN]: An earnings per share (EPS) analysis
The progress of the company may be observed through the prism of EPS growth rate, while Wall Street analysts are focusing on predicting the 5-year EPS growth rate for MRSN. When it comes to the mentioned value, analysts are expecting to see the 5-year EPS growth rate for Mersana Therapeutics Inc go to -8.65%.
An analysis of Institutional ownership at Mersana Therapeutics Inc [MRSN]
There are presently around $71.48%, or 72.56% of MRSN stock, in the hands of institutional investors. The top three institutional holders of MRSN stocks are: ECOR1 CAPITAL, LLC with ownership of 19.36 million shares, which is approximately 15.8156%. VR ADVISER, LLC, holding 11.33 million shares of the stock with an approximate value of $$22.77 million in MRSN stocks shares; and VR ADVISER, LLC, currently with $$19.15 million in MRSN stock with ownership which is approximately 7.7802%.
